Doctor profile · Federal record

Dr. Mitchell Akman, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Specialist · Redding, CA

  • NPI 1831266345
  • Accepts Medicare
  • 39 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1555 East St, Suite 300
Redding, CA 960011153
(530) 229-1844
fax (530) 243-6397
Mailing address
Po Box 6971
Lincoln, NE 685060971

Credentials & registration

NPPES · NUCC
NPI registered
November 2006 — 20 yrs on file
Profile last updated
January 19, 2024
Year of graduation
1987 — 39 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
California #A54308

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1831266345. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,992
Distinct HCPCS
7
Medicare allowed
$310,989
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 1,300 658 $130
99213 Established patient office or other outpatient visit, 20-29 minutes 865 504 $91
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 259 95 $34
G0008 Administration of influenza virus vaccine 204 201 $31
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage 161 161 $75
99205 New patient office or other outpatient visit, 60-74 minutes 158 158 $222
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free 45 43 $33

In context: peer comparison

Among 2 peers in Redding Endocrinology, Diabetes & Metabolism Physician, average services per provider: 375. This provider delivers 8.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,208
Transactions
69
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Novo Nordisk INC 19 $271.22
Amgen INC. 20 $236.71
Boehringer Ingelheim Pharmaceuticals, INC. 8 $202.25
Lilly USA, LLC 8 $185.79
Radius Health, INC. 1 $49.54
Abbvie INC. 2 $46.12
Beta Bionics, INC. 3 $36.66
Tandem Diabetes Care, INC. 2 $32.42
Kyowa Kirin, INC. 1 $28.03
Insulet Corporation 1 $26.86
Abbott Laboratories 1 $26.24
Xeris Pharmaceuticals, INC. 1 $22.63
Ascendis Pharma INC 1 $22.50
Medtronic, INC. 1 $20.91

By nature of payment

Food and Beverage
$1,208

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,325
Patients
1,231
Total drug cost
$1,715,988
Drug Type Claims Patients Total cost
Levoxyl (Levothyroxine Sodium) Brand 1,217 324 $36,637
Synthroid (Levothyroxine Sodium) Brand 711 179 $85,875
Ozempic (Semaglutide) Brand 400 107 $748,384
Atorvastatin Calcium Generic 333 110 $5,116
Rosuvastatin Calcium Generic 234 73 $7,020
Pioglitazone Hcl Generic 207 61 $5,464
Metformin Hcl ER (Metformin Hcl) Brand 204 64 $5,729
Jardiance (Empagliflozin) Brand 179 56 $247,663
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 146 46 $145,243
Calcitriol Generic 131 36 $7,636

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mitchell Akman's medical specialty?
Dr. Mitchell Akman practices Endocrinology, Diabetes & Metabolism Physician in Redding, CA.
Where does Dr. Mitchell Akman practice?
Dr. Mitchell Akman practices at 1555 East St, Redding, CA 960011153. Office phone: 5302291844.
What is Dr. Mitchell Akman's NPI?
Dr. Mitchell Akman's National Provider Identifier (NPI) is 1831266345, issued by NPPES.
Does Dr. Mitchell Akman accept Medicare assignment?
Yes. Dr. Mitchell Akman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mitchell Akman commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.